mTOR-dependent signalling in Alzheimer's disease

Journal of Cellular and Molecular Medicine

Volumn 12, Issue 6B, 2008, Pages 2525-2532

  Pei, Jin Jing ^a   Hugon, Jacques ^b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b INSERM   (France)

Author keywords

Alzheimer's disease; mTOR; Neurodegeneration; Neurofibrillary degeneration

Indexed keywords

MAMMALIAN TARGET OF RAPAMYCIN; PROTEIN KINASE; TAU PROTEIN;

ALZHEIMER DISEASE; ANIMAL; HUMAN; METABOLISM; NERVE DEGENERATION; PATHOLOGY; PROTEIN SYNTHESIS; REVIEW; SIGNAL TRANSDUCTION;

ALZHEIMER DISEASE; ANIMALS; HUMANS; NERVE DEGENERATION; PROTEIN BIOSYNTHESIS; PROTEIN KINASES; SIGNAL TRANSDUCTION; TAU PROTEINS;

EID: 58149463424     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2008.00509.x     Document Type: Review

References (69)

1. Tee AR, Blenis J, Proud CG. Analysis of mTOR signaling by the small G-proteins, Rheb and RhebL1. FEBS Lett. 2005 579 : 4763 8.
2. Siekierka JJ, Hung SH, Poe M, Lin CS, Sigal NH. A cytosolic binding protein for the immunosuppressant FK506 has peptidyl-prolyl isomerase activity but is distinct from cyclophilin. Nature. 1989 341 : 755 7.
3. Swiech L, Perycz M, Malik A, Jaworski J. Role of mTOR in physiology and pathology of the nervous system. Biochim Biophys Acta. 2008 1784 : 116 32.
4. Bhaskar PT, Hay N. The two TORCs and Akt. Dev Cell. 2007 12 : 487 502.
5. Kim DH, Sarbassov DD, Ali SM, King JE, Latek RR, Erdjument-Bromage H, Tempst P, Sabatini DM. mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery. Cell. 2002 110 : 163 75.
6. Wullschleger S, Loewith R, Oppliger W, Hall MN. Molecular organization of target of rapamycin complex 2. J Biol Chem. 2005 280 : 30697 704.
7. Reiling JH, Sabatini DM. Increased mTORC1 signaling UPRegulates stress. Mol Cell. 2008 29 : 533 5.
8. Loewith R, Jacinto E, Wullschleger S, Lorberg A, Crespo JL, Bonenfant D, Oppliger W, Jenoe P, Hall MN. Two TOR complexes, only one of which is rapamycin sensitive, have distinct roles in cell growth control. Mol Cell. 2002 10 : 457 68.
9. Wullschleger S, Loewith R, Hall MN. TOR signaling in growth and metabolism. Cell. 2006 124 : 471 84.
10. Jacinto E, Hall MN. Tor signalling in bugs, brain and brawn. Nat Rev Mol Cell Biol. 2003 4 : 117 26.
11. Kwon CH, Zhu X, Zhang J, Baker SJ. mTor is required for hypertrophy of Pten-deficient neuronal soma in vivo. Proc Natl Acad Sci USA. 2003 100 : 12923 8.
12. Jaworski J, Sheng M. The growing role of mTOR in neuronal development and plasticity. Mol Neurobiol. 2006 34 : 205 19.
13. Zhou XW, Li X, Bjorkdahl C, Sjogren MJ, Alafuzoff I, Soininen H, Grundke-Iqbal I, Iqbal K, Winblad B, Pei JJ. Assessments of the accumulation severities of amyloid beta-protein and hyperphosphorylated tau in the medial temporal cortex of control and Alzheimer's brains. Neurobiol Dis. 2006 22 : 657 68.
14. Dickson DW. Apoptotic mechanisms in Alzheimer neurofibrillary degeneration: cause or effect? J Clin Invest. 2004 114 : 23 7.
15. Lafay-Chebassier C, Perault-Pochat MC, Page G, Rioux Bilan A, Damjanac M, Pain S, Houeto JL, Gil R, Hugon J. The immunosuppressant rapamycin exacerbates neurotoxicity of Abeta peptide. J Neurosci Res. 2006 84 : 1323 34.
16. Zhou XW, Gustafsson JA, Tanila H, Bjorkdahl C, Liu R, Winblad B, Pei JJ. Tau hyperphosphorylation correlates with reduced methylation of protein phos-phatase 2A. Neurobiol Dis. 2008 31 : 386 94.
17. Liu R, Zhou XW, Tanila H, Bjorkdahl C, Wang JZ, Guan ZZ, Cao Y, Gustafsson J A. Winblad B. Pei JJ. Phosphorylated PP2A {tyrosine 307} is associated with Alzheimer neurofibrillary pathology. J Cell Mol Med. 2008 12 : 241 57.
18. Langstrom N, Eriksson A, Winblad B, Wallace W. Translational control of gene expression in the human brain. Prog Neuropsychopharmacol Biol Psychiatry. 1989 13 : 469 79.
19. Sajdel-Sulkowska EM, Marotta CA. Alzheimer's disease brain: alterations in RNA levels and in a ribonuclease-inhibitor complex. Science. 1984 225 : 947 9.
20. Onuki R, Bando Y, Suyama E, Katayama T, Kawasaki H, Baba T, Tohyama M, Taira K. An RNA-dependent protein kinase is involved in tunicamycin-induced apoptosis and Alzheimer's disease. EMBO J. 2004 23 : 959 68.
21. Peel AL, Bredesen DE. Activation of the cell stress kinase PKR in Alzheimer's disease and human amyloid precursor protein transgenic mice. Neurobiol Dis. 2003 14 : 52 62.
22. Chang RC, Wong AK, Ng HK, Hugon J. Phosphorylation of eukaryotic initiation factor-2alpha {eIF2alpha} is associated with neuronal degeneration in Alzheimer's disease. Neuroreport. 2002 13 : 2429 32.
23. An WL, Cowburn RF, Li L, Braak H, Alafuzoff I, Iqbal K, Grundke-Iqbal I, Winblad B, Pei JJ. Up-regulation of phos-phorylated/activated p70 S6 kinase and its relationship to neurofibrillary pathology in Alzheimer's disease. Am J Pathol. 2003 163 : 591 607.
24. Chang RC, Suen KC, Ma CH, Elyaman W, Ng HK, Hugon J. Involvement of double- stranded RNA-dependent protein kinase and phosphorylation of eukaryotic initiation factor-2alpha in neuronal degeneration. J Neurochem. 2002 83 : 1215 25.
25. Suen KC, Yu MS, So KF, Chang RC, Hugon J. Upstream signaling pathways leading to the activation of double-stranded RNA-dependent serine/threonine protein kinase in beta-amyloid peptide neurotoxicity. J Biol Chem. 2003 278 : 49819 27.
26. Page G, Rioux Bilan A, Ingrand S, Lafay-Chebassier C, Pain S, Perault Pochat MC, Bouras C, Baye, T, Hugon J. Activated double-stranded RNA-dependent protein kinase and neuronal death in models of Alzheimer's disease. Neuroscience. 2006 139 : 1343 54.
27. Li X, An WL, Alafuzoff I, Soininen H, Winblad B, Pei JJ. Phosphorylated eukaryotic translation factor 4E is elevated in Alzheimer brain. Neuroreport. 2004 15 : 2237 40.
28. Li X, Alafuzoff I, Soininen H, Winblad B, Pei JJ. Levels of mTOR and its downstream targets 4E-BP1, eEF2, and eEF2 kinase in relationships with tau in Alzheimer's disease brain. FEBS J. 2005 272 : 4211 20.
29. Pei J, Björkdahl C, Zhang H, Zhou X, Winblad B. p70 S6 Kinase and Tau in Alzheimer's Disease. J Alzheimer's Dis. 2008 14 : 1 8.
30. Paschen W, Djuricic B, Mies G, Schmidt-Kastner R, Linn F. Lactate and pH in the brain: association and dissociation in different pathophysiological states. J Neurochem. 1987 48 : 154 9.
31. Clauberg M, Joshi JG. Regulation of serine protease activity by aluminum: implications for Alzheimer disease. Proc Natl Acad Sci USA. 1993 90 : 1009 12.
32. Dorovkov MV, Pavur KS, Petrov AN, Ryazanov AG. Regulation of elongation factor-2 kinase by pH. Biochemistry. 2002 41 : 13444 50.
33. Liu R, Pei JJ, Wang XC, Zhou XW, Tian Q, Winblad B, Wang JZ. Acute anoxia induces tau dephosphorylation in rat brain slices and its possible underlying mechanisms. J Neurochem. 2005 94 : 1225 34.
34. Wen Y, Yang S, Liu R, Brun-Zinkernagel AM, Koulen P, Simpkins JW. Transient cerebral ischemia induces aberrant neuronal cell cycle re-entry and Alzheimer's disease-like tauopathy in female rats. J Biol Chem. 2004 279 : 22684 92.
35. Yates CM, Butterworth J, Tennant MC, Gordon A. Enzyme activities in relation to pH and lactate in postmortem brain in Alzheimer-type and other dementias. J Neurochem. 1990 55 : 1624 30.
36. Langstrom NS, Anderson JP, Lindroos HG, Winblad B, Wallace WC. Alzheimer's disease-associated reduction of polysomal mRNA translation. Brain Res Mol Brain Res. 1989 5 : 259 69.
37. Ding Q, Markesbery WR, Chen Q, Li F, Keller JN. Ribosome dysfunction is an early event in Alzheimer's disease. J Neurosci. 2005 25 : 9171 5.
38. Shenton D, Smirnova JB, Selley JN, Carroll K, Hubbard SJ, Pavitt GD, Ashe MP, Grant CM. Global translational responses to oxidative stress impact upon multiple levels of protein synthesis. J Biol Chem. 2006 281 : 29011 21.
39. Honda K, Smith MA, Zhu X, Baus D, Merrick WC, Tartakoff AM, Hattier T, Harris PL, Siedlak SL, Fujioka H, Liu Q, Moreira PI, Miller FP, Nunomura A, Shimohama S, Perry G. Ribosomal RNA in Alzheimer disease is oxidized by bound redox-active iron. J Biol Chem. 2005 280 : 20978 86.
40. Smirnova JB, Selley JN, Sanchez-Cabo F, Carroll K, Eddy AA, McCarthy JE, Hubbard SJ, Pavitt GD, Grant CM, Ashe MP. Global gene expression profiling reveals widespread yet distinctive translational responses to different eukaryotic translation initiation factor 2B-targeting stress pathways. Mol Cell Biol. 2005 25 : 9340 9.
41. Preiss T, Baron-Benhamou J, Ansorge W, Hentze MW. Homodirectional changes in transcriptome composition and mRNA translation induced by rapamycin and heat shock. Nat Struct Biol. 2003 10 : 1039 47.
42. Khurana V, Lu Y, Steinhilb ML, Oldham S, Shulman JM, Feany MB. TOR-mediated cell-cycle activation causes neurode-generation in a Drosophila tauopathy model. Curr Biol. 2006 16 : 230 41.
43. Rogaeva E, Kawarai T, George-Hyslop PS. Genetic complexity of Alzheimer's disease: successes and challenges. J Alzheimers Dis. 2006 9 : 381 7.
44. Boutajangout A, Boom A, Leroy K, Brion J P. Expression of tau mRNA and soluble tau isoforms in affected and non-affected brain areas in Alzheimer's disease. FEBS Lett. 2004 576 : 183 9.
45. Chambers CB, Lee JM, Troncoso JC, Reich S, Muma NA. Overexpression of four-repeat tau mRNA isoforms in progressive supranuclear palsy but not in Alzheimer's disease. Ann Neurol. 1999 46 : 325 32.
46. Mah VH, Eskin TA, Kazee AM, Lapham L, Higgins GA. In situ hybridization of calcium/calmodulin dependent protein kinase II and tau mRNAs; species differences and relative preservation in Alzheimer's disease. Brain Res Mol Brain Res. 1992 12 : 85 94.
47. Pearson RB, Dennis PB, Han JW, Williamson NA, Kozma SC, Wettenhall RE, Thomas G. The principal target of rapamycin-induced p70s6k inactivation is a novel phosphorylation site within a conserved hydrophobic domain. EMBO J. 1995 14 : 5279 87.
48. An WL, Bjorkdahl C, Liu R, Cowburn RF, Winblad B, Pei JJ. Mechanism of zinc-induced phosphorylation of p70 S6 kinase and glycogen synthase kinase 3beta in SH-SY5Y neuroblastoma cells. J Neurochem. 2005 92 : 1104 15.
49. Lafay-Chebassier C, Paccalin M, Page G, Barc-Pain S, Perault-Pochat MC, Gil R, Pradier L, Hugon J. mTOR/p70S6k signalling alteration by Abeta exposure as well as in APP-PS1 transgenic models and in patients with Alzheimer's disease. J Neurochem. 2005 94 : 215 25.
50. Björkdahl C. Tau and neurofilament proteins in Alzheimer's disease and related cell models. Thesis Karolinska Institutet 2007.
51. Pei JJ, Gong CX, An WL, Winblad B, Cowburn RF, Grundke-Iqbal I, Iqbal K. Okadaic-acid-induced inhibition of protein phosphatase 2A produces activation of mitogen-activated protein kinases ERK1/2, MEK1/2, and p70 S6, similar to that in Alzheimer's disease. Am J Pathol. 2003 163 : 845 58.
52. An WL. Role of p70 S6 kinase in the formation of tau pathogenesis in Alzheimer's disease. Thesis Karolinska Institutet 2005.
53. Meske V, Albert F, Ohm TG. Coupling of mammalian target of rapamycin with phosphoinositide 3-kinase signaling pathway regulates protein phosphatase 2A-and glycogen synthase kinase-3 -dependent phosphorylation of Tau. J Biol Chem. 2008 283 : 100 9.
54. Pei JJ, An WL, Zhou XW, Nishimura, T, Norberg J, Benedikz E, Gotz J, Winblad B. P70 S6 kinase mediates tau phosphory-lation and synthesis. FEBS Lett. 2006 580 : 107 14.
55. Virdee K, Yoshida H, Peak-Chew S, Goedert M. Phosphorylation of human microtubule-associated protein tau by protein kinases of the AGC subfamily. FEBS Lett. 2007 581 : 2657 62.
56. Zhou XW, Tanila H, Pei JJ. Parallel increase in p70 kinase activation and tau phosphorylation {S262} with Abeta overproduction. FEBS Lett. 2008 582 : 159 64.
57. Paccalin M, Pain-Barc S, Pluchon C, Paul C, Bazin H, Gil R, Hugon J. The relation between p70S6k expression in lymphocytes and the decline of cognitive test scores in patients with Alzheimer disease. Arch Intern Med. 2005 165 : 2428 9.
58. Paccalin M, Al Khidir F, Barc S P, Pluchon C, Perrault-Pochat MC, Gil R, Hugon J. Peripheral p70S6k levels and emotional memory in patients with Alzheimer's disease. Neurosci Lett. 2006 410 : 162 4.
59. Paccalin M, Pain-Barc S, Pluchon C, Paul C, Besson MN, Carret-Rebillat AS, Rioux-Bilan A, Gil R, Hugon J. Activated mTOR and PKR kinases in lymphocytes correlate with memory and cognitive decline in Alzheimer's disease. Dement Geriatr Cogn Disord. 2006 22 : 320 6.
60. Morimoto N, Nagai M, Ohta Y, Miyazaki K, Kurata T, Morimoto M, Murakami T, Takehisa Y, Ikeda Y, Kamiya T, Abe K. Increased autophagy in transgenic mice with a G93A mutant SOD1 gene. Brain Res. 2007 1167 : 112 7.
61. Malagelada C, Ryu EJ, Biswas SC, Jackson-Lewis V, Greene LA. RTP801 is elevated in Parkinson brain substantia nigral neurons and mediates death in cellular models of Parkinson's disease by a mechanism involving mammalian target of rapamycin inactivation. J Neurosci. 2006 26 : 9996 10005.
62. Ravikumar B, Vacher C, Berger Z, Luo S, Oroz LG, Scaravilli F, Easton DF, Duden R, O'Kane CJ, Rubinsztein DC. Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease. Nat Genet. 2004 36 : 585 95.
63. Chen L, Liu L, Luo Y, Huang S. MAPK and mTOR pathways are involved in cadmium-induced neuronal apoptosis. J Neurochem. 2008 105 : 251 61.
64. Wu X, Reiter CE, Antonetti DA, Kimball SR, Jefferson LS, Gardner TW. Insulin promotes rat retinal neuronal cell survival in a p70S6K-dependent manner. J Biol Chem. 2004 279 : 9167 75.
65. Vogt BA, Van Hoesen GW, Vogt LJ. Laminar distribution of neuron degeneration in posterior cingulate cortex in Alzheimer's disease. Acta Neuropathol. 1990 80 : 581 9.
66. Lesort M, Blanchard C, Yardin C, Esclaire F, Hugon J. Cultured neurons expressing phosphorylated tau are more resistant to apoptosis induced by NMDA or serum deprivation. Brain Res Mol Brain Res. 1997 45 : 127 32.
67. Yardin C, Terro F, Lesort M, Esclaire F, Hugon J. FK506 antagonizes apoptosis and c-jun protein expression in neuronal cultures. Neuroreport. 1998 9 : 2077 80.
68. Elyaman W, Terro F, Suen KC, Yardin C, Chang RC, Hugon J. BAD and Bcl-2 reguation are early events linking neuronal endoplasmic reticulum stress to mitochondria-mediated apoptosis. Brain Res Mol Brain Res. 2002 109 : 233 8.
69. Mills JC, Lee VM, Pittman RN. Activation of a PP2A-like phosphatase and dephosphorylation of tau protein characterize onset of the execution phase of apoptosis. J Cell Sci. 1998 111 : 625 36.